series-a
Stage
1
Investors
About
Colospan develops CG-100, a CE-marked, minimally invasive intraluminal bypass device designed to reduce complications and avoid the need for diverting stomas after colorectal surgery, improving patient outcomes and reducing healthcare costs.
Explore Colospan's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.